Testosterone Patch, Not So Hot?

According to Drug and Therapeutics Bulletin (DTB), the testosterone patch, called Intrinsa, was recently licensed in the UK for the treatment of women who have gone through surgery-induced menopause and consequently experiencing lowered sex drive, a condition called hypoactive sexual desire disorder (HSDD) to be given along with estrogen replacement therapy. But it turns out there were some problems with the main trials on the patches.